Insulet Financial Statements From 2010 to 2026

PODD Stock  USD 239.11  3.78  1.56%   
Insulet's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Insulet's valuation are provided below:
Gross Profit
1.9 B
Profit Margin
0.0912
Market Capitalization
17.1 B
Enterprise Value Revenue
6.3726
Revenue
2.7 B
There are over one hundred nineteen available fundamental trends for Insulet, which can be analyzed over time and compared to other ratios. Investors should ensure to confirm all of Insulet's regular performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road. The current year's Market Cap is expected to grow to about 9.8 B. The current year's Enterprise Value is expected to grow to about 10.5 B

Insulet Total Revenue

2.84 Billion

Check Insulet financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Insulet's main balance sheet or income statement drivers, such as Interest Expense of 83.7 M, Other Operating Expenses of 2.3 B or Operating Income of 497.5 M, as well as many indicators such as Price To Sales Ratio of 7.01, Dividend Yield of 0.0 or PTB Ratio of 19.5. Insulet financial statements analysis is a perfect complement when working with Insulet Valuation or Volatility modules.
  
Build AI portfolio with Insulet Stock
Check out the analysis of Insulet Correlation against competitors.
For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.

Insulet Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets3.3 B3.2 B1.4 B
Slightly volatile
Cash751.9 M716.1 M419.5 M
Slightly volatile
Other Assets1.091.1524.1 M
Pretty Stable
Cash And Short Term Investments751.9 M716.1 M443.2 M
Slightly volatile
Common Stock Shares Outstanding47.6 M71.9 M57.1 M
Slightly volatile
Liabilities And Stockholders Equity3.3 B3.2 B1.4 B
Slightly volatile
Total Liabilities1.8 B1.7 B911.1 M
Slightly volatile
Total Current AssetsB1.9 B823.2 M
Slightly volatile
Short and Long Term Debt Total529.7 M1.1 B665.5 M
Slightly volatile
Total Current Liabilities714.1 M680.1 M224.6 M
Slightly volatile
Short Term Debt21.1 M22.2 M51 M
Very volatile
Property Plant And Equipment Net906.4 M863.2 M343.2 M
Slightly volatile
Accounts Payable78.8 M75 M29.7 M
Slightly volatile
Non Current Assets Total1.4 B1.3 B531.3 M
Slightly volatile
Non Currrent Assets Other175.7 M167.3 M66.5 M
Slightly volatile
Common Stock Total Equity120.8 K115 K75 K
Slightly volatile
Non Current Liabilities Total555.4 M995.1 M659.7 M
Slightly volatile
Property Plant And Equipment Gross1.3 B1.3 B447.7 M
Slightly volatile
Common Stock64.1 K115 K71.7 K
Slightly volatile
Other Liabilities5.4 M9.5 M6.6 M
Slightly volatile
Long Term Debt581.5 M930.8 M640.9 M
Slightly volatile
Net Receivables542.7 M516.9 M155.8 M
Slightly volatile
Inventory475.2 M452.6 M168.8 M
Slightly volatile
Property Plant Equipment724.4 M689.9 M306.1 M
Slightly volatile
Good Will45.8 M51.6 M41 M
Slightly volatile
Long Term Debt Total1.7 B1.6 B754 M
Slightly volatile
Capital Surpluse899.1 M1.2 B852.8 M
Slightly volatile
Non Current Liabilities Other67.4 M64.2 M20.3 M
Slightly volatile
Intangible Assets123 M117.1 M42.4 M
Slightly volatile
Capital Lease Obligations230 K242.1 K1.6 M
Slightly volatile
Short and Long Term Debt17.5 M18.4 M129.7 M
Slightly volatile
Net Invested Capital1.7 B2.5 B1.2 B
Slightly volatile
Net Working Capital983.9 M1.2 B717.2 M
Slightly volatile
Capital Stock104.4 K115 K79.4 K
Slightly volatile

Insulet Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses2.3 B2.2 B843 M
Slightly volatile
Research Development316.2 M301.1 M119.3 M
Slightly volatile
Total Operating Expenses1.5 B1.5 B530.3 M
Slightly volatile
Selling And Marketing Expenses74.5 M96.9 M75.1 M
Slightly volatile
Depreciation And Amortization118.8 M113.1 M40.7 M
Slightly volatile
Selling General Administrative1.2 B1.2 B350.8 M
Slightly volatile
Total Revenue2.8 B2.7 B936.8 M
Slightly volatile
Cost Of Revenue806.6 M768.2 M312.8 M
Slightly volatile
Interest Income36.4 M34.7 M15.4 M
Slightly volatile
Reconciled Depreciation58 M90.4 M37 M
Slightly volatile

Insulet Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash FlowB953.4 M382.7 M
Slightly volatile
Depreciation94.9 M90.4 M38 M
Slightly volatile
Capital Expenditures201.2 M191.6 M89.8 M
Slightly volatile
End Period Cash Flow751.9 M716.1 M404.7 M
Slightly volatile
Change To Liabilities158.8 M151.2 M51.9 M
Slightly volatile
Stock Based Compensation65.8 M62.7 M32.5 M
Slightly volatile
Change To Netincome40.7 M55.1 M38 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio7.017.383714.8419
Slightly volatile
Days Sales Outstanding73.669.668259.025
Pretty Stable
Stock Based Compensation To Revenue0.0220.02320.0495
Slightly volatile
Capex To Depreciation3.192.11953.0664
Very volatile
EV To Sales7.137.507317.6898
Slightly volatile
Inventory Turnover1.611.69734.6556
Slightly volatile
Days Of Inventory On Hand226215149
Slightly volatile
Payables Turnover8.1710.242711.0475
Slightly volatile
Research And Ddevelopement To Revenue0.110.111212.79
Slightly volatile
Capex To Revenue0.06720.07086.5341
Slightly volatile
Cash Per Share16.0510.179410.5551
Very volatile
Days Payables Outstanding66.6735.635361.8095
Slightly volatile
Intangibles To Total Assets0.05020.05290.1135
Slightly volatile
Current Ratio2.642.777127.1144
Slightly volatile
Receivables Turnover4.945.23916.8481
Very volatile
Graham Number43.3241.258311.492
Slightly volatile
Capex Per Share3.172.72361.9436
Very volatile
Average Receivables24.6 M29.9 M31.6 M
Very volatile
Revenue Per Share40.4238.495814.1355
Slightly volatile
Interest Debt Per Share8.6216.070110.7239
Slightly volatile
Debt To Assets0.410.32940.542
Pretty Stable
Operating Cycle271285258
Very volatile
Days Of Payables Outstanding66.6735.635361.8095
Slightly volatile
Ebt Per Ebit0.680.71651.337
Slightly volatile
Quick Ratio2.012.111626.5412
Slightly volatile
Net Income Per E B T1.030.72780.9413
Slightly volatile
Cash Ratio1.01.052925.4067
Slightly volatile
Cash Conversion Cycle204249196
Very volatile
Days Of Inventory Outstanding226215149
Slightly volatile
Days Of Sales Outstanding73.669.668259.025
Pretty Stable
Fixed Asset Turnover4.363.13734.2761
Slightly volatile
Debt Ratio0.410.32940.542
Pretty Stable
Price Sales Ratio7.017.383714.8419
Slightly volatile
Asset Turnover0.470.84880.6728
Pretty Stable

Insulet Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap9.8 B9.3 B7.1 B
Slightly volatile
Enterprise Value10.5 B10 B7.6 B
Slightly volatile

Insulet Fundamental Market Drivers

Forward Price Earnings39.0625
Cash And Short Term Investments716.1 M

Insulet Upcoming Events

22nd of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Insulet Financial Statements

Insulet stakeholders use historical fundamental indicators, such as Insulet's revenue or net income, to determine how well the company is positioned to perform in the future. Although Insulet investors may analyze each financial statement separately, they are all interrelated. For example, changes in Insulet's assets and liabilities are reflected in the revenues and expenses on Insulet's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Insulet. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue14 M14.7 M
Total Revenue2.7 B2.8 B
Cost Of Revenue768.2 M806.6 M
Stock Based Compensation To Revenue 0.02  0.02 
Research And Ddevelopement To Revenue 0.11  0.11 
Capex To Revenue 0.07  0.07 
Revenue Per Share 38.50  40.42 
Ebit Per Revenue 0.17  0.18 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Insulet is a strong investment it is important to analyze Insulet's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insulet's future performance. For an informed investment choice regarding Insulet Stock, refer to the following important reports:
Check out the analysis of Insulet Correlation against competitors.
For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Will Health Care Equipment & Supplies sector continue expanding? Could Insulet diversify its offerings? Factors like these will boost the valuation of Insulet. Anticipated expansion of Insulet directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Insulet data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
0.039
Earnings Share
3.48
Revenue Per Share
38.496
Quarterly Revenue Growth
0.312
Return On Assets
0.0943
Understanding Insulet requires distinguishing between market price and book value, where the latter reflects Insulet's accounting equity. The concept of intrinsic value - what Insulet's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Insulet's price substantially above or below its fundamental value.
It's important to distinguish between Insulet's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Insulet should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Insulet's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.